Sequential single-agent obatoclax mesylate (GX15-070MS) followed by combination with rituximab in patients with previously untreated follicular lymphoma

Leuk Lymphoma. 2014 Dec;55(12):2932-4. doi: 10.3109/10428194.2014.900760. Epub 2014 Apr 22.

Authors

André Goy¹, Mark Berger, Peggy Ford, Tatyana Feldman, Anthony Mato, Colleen Bejot, Henry C Fung

Affiliation

¹ John Theurer Cancer Center, Hackensack University Medical Center , Hackensack, NJ , USA.

PMID: 24611663
DOI: 10.3109/10428194.2014.900760

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Murine-Derived / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Drug Administration Schedule
Humans
Indoles
Lymphoma, Follicular / drug therapy*
Pyrroles / administration & dosage
Rituximab
Treatment Outcome

Substances

Antibodies, Monoclonal, Murine-Derived
Indoles
Pyrroles
Rituximab
obatoclax